Obstructive sleep apnoea syndrome

9 clinical trials

Quick filters

Clinical trials for Obstructive sleep apnoea syndrome

9 trials across Europe

See all trials →

Quick filters

9 Clinical trials

Obstructive sleep apnoea syndrome

Recruiting

Investigational

A study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure

Investigational

Denmark

Participants:18–64 years · 65+ years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Obstructive sleep apnoea syndrome

Recruiting

Investigational

Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

Investigational

Germany

Participants:18–64 years · 65+ years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Obstructive sleep apnoea syndrome

Recruiting

Investigational

Study of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Obstructive sleep apnoea syndrome

Recruiting

InvestigationalNo placebo

A Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Obstructive sleep apnoea syndrome+1

Recruiting

Registered drug

Study on the Effect of Aprepitant on Aldosterone Levels in Patients with Obstructive Sleep Apnea and High Blood Pressure

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Lactose Monohydrate
Sponsor:Centre Hospitalier Universitaire Rouen

Contact Research Centre

Obesity+1

Not yet recruiting

Registered drugNo placebo

Tirzepatide versus CPAP and Lifestyle Modification for Obstructive Sleep Apnea in Adults ≥ 65 years with Overweight or Obesity – Randomized Trial

Registered drugNo placebo

Spain

Participants:65+ years
Substances:Tirzepatide
Sponsor:Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre

Contact Research Centre

See all trials →

Obstructive sleep apnoea syndrome

Clinical trials for Obstructive sleep apnoea syndrome

Obstructive sleep apnoea syndrome

A study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure

Obstructive sleep apnoea syndrome

Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

Obstructive sleep apnoea syndrome

Study of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy

Obstructive sleep apnoea syndrome

A Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)

Obstructive sleep apnoea syndrome+1

Study on the Effect of Aprepitant on Aldosterone Levels in Patients with Obstructive Sleep Apnea and High Blood Pressure

Obesity+1

Tirzepatide versus CPAP and Lifestyle Modification for Obstructive Sleep Apnea in Adults ≥ 65 years with Overweight or Obesity – Randomized Trial

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.